Teva’s interim legal chief sells 68.7% of holding after option exercise (NYSE: TEVA)
What happened Teva Pharmaceutical Industries Ltd (NYSE: TEVA) interim chief legal officer Dov Bergwerk sold 26,260 ordinary shares on Nov. 4. The sale, at $41.72 a share, brought in about $1.10 million and left him with 11,943 shares held directly. By OptimistFi's calculation, the shares sold were 68.7% of his holding before the trade. That […]
10 Nov 22:15 · The Markets Daily